A true English rose (!) with roots in the cider making counties, I studied at Leeds and Cambridge Universities where I developed a strong interest in disease mechanisms, drug mechanisms and pharmacogenomics. After a spell at GSK developing high throughput cellular assays, I joined Sanger in late 2007 as a postdoctoral fellow to explore the role of faulty DNA repair processes and mutations in cancer and rare diseases using model systems. I am very excited to now lead a small team in the wet lab arm of the Anderson Group, where we use the latest technology to better understand how rare genetic variants (identified by the computational arm of the group), predispose to auto-inflammatory diseases. Most of my time outside of work is now dedicated to having fun with my young family, but I am still partial to a girls’ night/weekend, dinner parties and cycling.
